These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 27053530)
1. The clinical applications of genome editing in HIV. Wang CX; Cannon PM Blood; 2016 May; 127(21):2546-52. PubMed ID: 27053530 [TBL] [Abstract][Full Text] [Related]
2. Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases. Li L; Krymskaya L; Wang J; Henley J; Rao A; Cao LF; Tran CA; Torres-Coronado M; Gardner A; Gonzalez N; Kim K; Liu PQ; Hofer U; Lopez E; Gregory PD; Liu Q; Holmes MC; Cannon PM; Zaia JA; DiGiusto DL Mol Ther; 2013 Jun; 21(6):1259-69. PubMed ID: 23587921 [TBL] [Abstract][Full Text] [Related]
3. Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing. Knipping F; Newby GA; Eide CR; McElroy AN; Nielsen SC; Smith K; Fang Y; Cornu TI; Costa C; Gutierrez-Guerrero A; Bingea SP; Feser CJ; Steinbeck B; Hippen KL; Blazar BR; McCaffrey A; Mussolino C; Verhoeyen E; Tolar J; Liu DR; Osborn MJ Mol Ther; 2022 Jan; 30(1):130-144. PubMed ID: 34737067 [TBL] [Abstract][Full Text] [Related]
4. Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template. Sather BD; Romano Ibarra GS; Sommer K; Curinga G; Hale M; Khan IF; Singh S; Song Y; Gwiazda K; Sahni J; Jarjour J; Astrakhan A; Wagner TA; Scharenberg AM; Rawlings DJ Sci Transl Med; 2015 Sep; 7(307):307ra156. PubMed ID: 26424571 [TBL] [Abstract][Full Text] [Related]
5. Clinical Applications of Genome Editing to HIV Cure. Wang CX; Cannon PM AIDS Patient Care STDS; 2016 Dec; 30(12):539-544. PubMed ID: 27854119 [TBL] [Abstract][Full Text] [Related]
6. Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates. Peterson CW; Wang J; Norman KK; Norgaard ZK; Humbert O; Tse CK; Yan JJ; Trimble RG; Shivak DA; Rebar EJ; Gregory PD; Holmes MC; Kiem HP Blood; 2016 May; 127(20):2416-26. PubMed ID: 26980728 [TBL] [Abstract][Full Text] [Related]
7. Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break. Rogers GL; Chen HY; Morales H; Cannon PM Mol Ther; 2019 Oct; 27(10):1726-1736. PubMed ID: 31540849 [TBL] [Abstract][Full Text] [Related]
8. Gene Editing: Regulatory and Translation to Clinic. Ando D; Meyer K Hematol Oncol Clin North Am; 2017 Oct; 31(5):797-808. PubMed ID: 28895848 [TBL] [Abstract][Full Text] [Related]
9. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Holt N; Wang J; Kim K; Friedman G; Wang X; Taupin V; Crooks GM; Kohn DB; Gregory PD; Holmes MC; Cannon PM Nat Biotechnol; 2010 Aug; 28(8):839-47. PubMed ID: 20601939 [TBL] [Abstract][Full Text] [Related]
10. A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection. Dudek AM; Feist WN; Sasu EJ; Luna SE; Ben-Efraim K; Bak RO; Cepika AM; Porteus MH Cell Stem Cell; 2024 Apr; 31(4):499-518.e6. PubMed ID: 38579682 [TBL] [Abstract][Full Text] [Related]
11. Designer Nucleases: Gene-Editing Therapies using CCR5 as an Emerging Target in HIV. Almeida MJ; Matos A Curr HIV Res; 2019; 17(5):306-323. PubMed ID: 31652113 [TBL] [Abstract][Full Text] [Related]
12. Editing CCR5: a novel approach to HIV gene therapy. Cornu TI; Mussolino C; Bloom K; Cathomen T Adv Exp Med Biol; 2015; 848():117-30. PubMed ID: 25757618 [TBL] [Abstract][Full Text] [Related]
13. The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV. Karuppusamy KV; Babu P; Thangavel S Stem Cell Rev Rep; 2021 Oct; 17(5):1607-1618. PubMed ID: 33788143 [TBL] [Abstract][Full Text] [Related]
14. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles. Yu KR; Natanson H; Dunbar CE Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988 [TBL] [Abstract][Full Text] [Related]
15. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
17. Customizing the genome as therapy for the β-hemoglobinopathies. Canver MC; Orkin SH Blood; 2016 May; 127(21):2536-45. PubMed ID: 27053533 [TBL] [Abstract][Full Text] [Related]
18. CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia. Xu L; Wang J; Liu Y; Xie L; Su B; Mou D; Wang L; Liu T; Wang X; Zhang B; Zhao L; Hu L; Ning H; Zhang Y; Deng K; Liu L; Lu X; Zhang T; Xu J; Li C; Wu H; Deng H; Chen H N Engl J Med; 2019 Sep; 381(13):1240-1247. PubMed ID: 31509667 [TBL] [Abstract][Full Text] [Related]
19. Recent developments in CCR5 regulation for HIV cure. Garg K; Khan AR; Taneja P Adv Protein Chem Struct Biol; 2021; 126():123-149. PubMed ID: 34090613 [TBL] [Abstract][Full Text] [Related]
20. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Schiroli G; Ferrari S; Conway A; Jacob A; Capo V; Albano L; Plati T; Castiello MC; Sanvito F; Gennery AR; Bovolenta C; Palchaudhuri R; Scadden DT; Holmes MC; Villa A; Sitia G; Lombardo A; Genovese P; Naldini L Sci Transl Med; 2017 Oct; 9(411):. PubMed ID: 29021165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]